Emerging technologies open new horizons in glaucoma structural evaluation, management
Michael H. Davidson, MD, discusses PCSK9 as a target of therapy
Regimen Selection in HIV: Considering New Options to Optimize Outcomes
Advances in Pharmacokinetic Enhancers in HIV Treatment: What You Need to Know to Optimize Outcomes
Maintenance pazopanib extended PFS, not OS in ovarian cancer
Journal of Psychosocial Nursing and Mental Health Services
Healio.com strives to be the global, definitive information source for medical professionals by delivering timely, accurate, authoritative and balanced reports on clinical issues, socioeconomic topics and industry developments, as well as presenting clinically relevant information on surgical techniques and medical therapies for the benefit of the patient.
News content is intended for informational purposes only and should not be used as the basis of patient treatment. All opinions expressed by authors and quoted sources are their own and do not necessarily reflect the opinions of the editors, publishers or editorial boards of the Wyanoke Group.
All news content on Healio.com is reviewed by the Editor who is solely responsible for deciding upon its acceptance, rejection or need for revision, based upon the appropriateness to the mission of the website. Quotes and other information in staff-written news reports are verified for accuracy prior to publication. Sources may not be contacted prior to publication to facilitate the rapid dissemination of this news. Unsolicited physician-written and other expert-written original content, such as blogs, editorials and commentary are encouraged but are subject to the editorial process and additional editorial review.
Because Healio.com reports on emerging technologies, techniques and medical therapies, some reports may discuss drug and device applications that either are not approved by the appropriate regulatory body and/or the U.S. Food and Drug Administration or are not considered to be within the standard practice of medicine. In lieu of placing a trademark symbol at each occurrence of a trademark name, we acknowledge here that the omission is due to the editorial nature of the publication and with no intention of trademark infringement.
In the interest of accountability and transparency in its reporting practices, Healio.com includes datelines with news content only if the editorial staff attended the presentation and/or meeting of the information on which he or she reported.
As a prerequisite for publication, all authors and quoted sources are asked to disclose fully and specifically any direct financial interest in products mentioned in news content, as well as their status as paid consultants or employees for any companies mentioned. In cases in which there is the need for rapid dissemination of this news, the reporter will seek this information through various sources so as to present the news in the context of the author’s or source’s financial disclosures.
The acceptance of advertising in no way implies endorsement by the editors, publishers or editorial boards of the Wyanoke Group. Healio.com does not publish articles on the basis of advertising support and purposely does not put editorial content next to an unintentionally related advertisement. Because the website is dynamically created, there may be unavoidable occasions when a related advertisement may be adjacent to related editorial. This in no way implies endorsement, malice or quid pro quo.
Contact any editorial staff member at Healio.com, c/o SLACK Incorporated, 6900 Grove Road, Thorofare, NJ 08086; 856-848-1000 or 800-257-8290; email: email@example.com.
About The Wyanoke Group »
Medical Disclaimer »
Public Access Policy »
©2014 All Rights Reserved.